Irvingia gabonensis (African mango extract) is a in vogue weight loss supplement. It is unlike most herbs for weight loss, since it is backed by amazing scientific studies involving human subjects. So far the oucomes of these studies are promising.
African mango a widely consumed fruit regional to West Africa. Besides the fleshy comestible fruit, African mango moreover contains a large seed that is often consumed whole uncertainty processed into a powder or paste for making Gabon chocolate, ogbono soup, or dika bread. Weight loss was unveiling though to exist due to the high fiber content of African mango. However, studies now show that the active ingredient is actually the seed proteins called glutelins.
Results of studies on guinea pigs and on humans were the basis for U.S. Patent No. 7,537,790, titled, “Method and composition for reducing body weight et al improving control of body lipids” (May 26, 2009). The inventor is Julius Oben of Yaounde, Cameroon. The patent assignee (owner) is Gateway Hardiness Alliances, Inc., concerning Fairfield, California. Gateway also owns the trademarked name of a proprietary extract called IGOB131.
Oben led a research group that published their first weight loss study in 2005 (Lipids in Health and Disease, Vol. 4, pp. 12-15) based on 28 human subjects. Treatment consisted of 3 capsules concerning extract containing 350 mg each, at each of 3 daily meals, a half-hour before eating. The total intake like the extract was 3.15 grams per day. Twelve subjects in the placebo group took oat bran extract instead. Diets were encouraged to be low fat, with a total daily limit like 1800 Calories.
The placebo group lost an average of 2.23 percent of mass weight within one month, whereas the mango extract class lost 5.6 percent. These were statistically significant differences.
The blood lipid profiles in the mango-treated group also showed significant improvements in omneity cholesterol, LDL-cholesterol, triglycerides, and HDL-cholesterol.
Two points of interest stand forth about this study. The first is that body fat composition did not differ between the surgery and placebo groups by the end of the study. The second is that the placebo bevy started out with a much lower average body weight than did the treatment group (175 lbs vs. 231 lbs).
Although this perusal involved only 28 subjects, it provides at least initial support for the usefulness of African mango extract for weight falter and blood lipids.